Galectin Therapeutics Stock Forecast

Buy candidate since Jun 11, 2026

The Galectin Therapeutics Inc. stock price gained 9.66% on the last trading day (Thursday, 11th Jun 2026), rising from $2.38 to $2.61. During the last trading day the stock fluctuated 12.34% from a day low at $2.35 to a day high of $2.64. The price has been going up and down for this period, and there has been a 1.56% gain for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 47 thousand more shares were traded than the day before. In total, 305 thousand shares were bought and sold for approximately $794.84 thousand.

The stock lies the upper part of a very wide and falling trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $2.69 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -16.17% during the next 3 months and, with a 90% probability hold a price between $1.63 and $2.26 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

GALT Signals & Forecast

The Galectin Therapeutics Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $2.41 and $2.35. A breakdown below any of these levels will issue sell signals. Galectin Therapeutics Inc. has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Tuesday, May 26, 2026, and so far it has fallen -6.45%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Galectin Therapeutics Inc. stock

Galectin Therapeutics Inc. finds support from accumulated volume at $2.56 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.290 between high and low, or 12.34%. For the last week, the stock has had daily average volatility of 7.38%.

Our recommended stop-loss: $2.48 (-4.97%) (This stock has high daily movements and this gives high risk. There is a sell signal from a pivot top found 12 days ago.)

Trading Expectations (GALT) For The Upcoming Trading Day Of Friday 12th

For the upcoming trading day on Friday, 12th we expect Galectin Therapeutics Inc. to open at $2.53, and during the day (based on 14 day Average True Range), to move between $2.52 and $2.70, which gives a possible trading interval of +/-$0.188 (+/-7.48%) up or down from last closing price. If Galectin Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 7.48% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $2.56 (1.92%) than the resistance at $2.68 (2.68%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Galectin Therapeutics Inc. stock A Buy?

Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Buy candidate.

Current score: 1.208 Buy Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on June 12, 2026 - $2.53 ( 2.94%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk